Ombow, Concerning MBRX, I see its co-founder is Dr. Priebe of the University of Texas MD Anderson Cancer Center, so not exactly chopped liver. That's one of the top cancer research centers in the country -
Moleculin - >>> Dr. Waldemar Priebe, Ph.D., is a Co-Founder of Moleculin Biotech, Inc. Dr. Priebe is a Professor of Medicinal Chemistry in the Section of Immunobiology and Drug Carriers in the Department of Bioimmunotherapy at MD Anderson. Dr. Priebe was a Founding Scientist and Scientific Advisor of Reata Pharmaceuticals, Inc. Using his chemical libraries and 'building block' approach, Dr. Priebe designs novel compounds that bind specifically to DNA and overcome multiple drug resistance. Dr. Priebe is the Founder and one of the Founding Scientists at Moleculin, LLC. Dr. Priebe is also a Professor of Medicinal Chemistry at the Department of Experimental Therapeutics at The University of Texas MD Anderson Cancer Center. He serves as Chairman of Scientific Advisory Board at Moleculin Biotech, Inc. Dr. Priebe served as the Chairman of the Scientific Advisory Board at Bering Exploration, Inc. (Formerly Oncolin Therapeutics Inc.), since July 2008. Dr. Priebe is an author of over 150 papers and inventor of numerous patents. As a Founder or Founding Scientist at a number of successful biotechnology firms such as Aronex Pharmaceuticals, Houston Pharmaceuticals, Reata Pharmaceuticals, and IntertechBio, Dr. Priebe has been integral in advancing several drugs through the pipeline, three of which are in clinical development. He has also developed several new small molecule compounds that have been licensed as potential drugs. He has a very successful record in cancer drug discovery and early stage development of a number of cancer therapeutics with 3 drugs in clinical trials and several in pre-clinical development. Dr. Priebe's oncology interests span a wide number of mechanistic areas including being the founding scientist of Oncolin's glycolysis inhibitors.
<<<
